Regorafenib Plus Nivolumab in Patients With Advanced Gastric or Colorectal Cancer: An Open-Label, Dose-Escalation, and Dose-Expansion Phase Ib Trial (REGONIVO, EPOC1603).
暂无分享，去创建一个
S. Nomura | A. Sato | T. Kuwata | T. Kojima | H. Nishikawa | K. Shitara | A. Kawazoe | H. Hara | N. Takahashi | M. Wakabayashi | Y. Togashi | M. Asayama | D. Kotani | S. Fukuoka | T. Yoshii | N. Hirano | H. Tamura | Y. Mikamoto